Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSGeneric

POTASSIUM PHOSPHATES

POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC

Standard Dose
4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary

Approval overview POTASSIUM PHOSPHATES is listed in Drugs@FDA under application 212121 (NDA).

Review priority: PRIORITY Marketing status: Discontinued Active ingredient POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC Form and strength SOLUTION;INTRAVENOUS - 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) Sponsor CMP DEV LLC Submission history Latest submission status date: 2019-09-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview POTASSIUM PHOSPHATES is listed in Drugs@FDA under application 212121 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC Form and strength SOLUTION;INTRAVENOUS - 4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML) Sponsor CMP DEV LLC Submission history Latest submission status date: 2019-09-19 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.
POTASSIUM PHOSPHATES (POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC) | Drug Monograph | MedicHelpline